Published in Biochem Soc Trans on January 01, 1978
Entrapment of plasmid DNA in liposomes. Nucleic Acids Res (1979) 0.78
The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem (1971) 3.73
The lesions in cell membranes caused by complement. Adv Immunol (1969) 2.81
Interferon action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature (1981) 2.49
Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. Nucleic Acids Res (1981) 2.42
Liposomes as immunological adjuvants. Nature (1974) 2.37
Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency. Gut (1982) 2.37
The carrier potential of liposomes in biology and medicine (first of two parts). N Engl J Med (1976) 2.03
Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature (1980) 2.03
Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. Biochem J (1972) 1.97
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J (1980) 1.97
The fixation of complement and the activated first component (C1) of complement by complexes formed between antibody and divalent hapten. J Exp Med (1970) 1.90
Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity. Clin Exp Immunol (1980) 1.88
Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol (1997) 1.87
Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem (2001) 1.86
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J Virol (1983) 1.81
Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. Eur J Biochem (1972) 1.74
Drug entrapment in liposomes. FEBS Lett (1973) 1.73
Morphologic changes in the membranes of red blood cells undergoing hemolysis. Am J Med (1966) 1.70
Morphological transformation of mouse embryo cells in vitro by murine sarcoma virus (Harvey). Nature (1967) 1.67
Enzyme-containing liposomes alleviate a model for storage disease. Nature (1973) 1.63
Interaction of Mycoplasma pneumoniae with human lung fibroblasts: characterization of the in vitro model. Infect Immun (1979) 1.62
Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55
Targeting of drugs. Nature (1977) 1.49
The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med (1976) 1.49
Electron microscopic studies of mouse immunoglobulin M; structure and reconstitution following reduction. Immunology (1970) 1.48
Catabolism of desialylated ceruloplasmin in the liver. J Biol Chem (1970) 1.47
Studies on the mechanism of influenza virus entry into cells. J Gen Virol (1979) 1.46
Homing of liposomes to target cells. Biochem Biophys Res Commun (1975) 1.46
Relationship of pili to colonial morphology among pathogenic and nonpathogenic species of Neisseria. Infect Immun (1977) 1.44
Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci (1982) 1.40
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta (1991) 1.37
Growth and effect of chlamydiae in human and bovine oviduct organ cultures. Br J Vener Dis (1979) 1.37
Molecular requirements for adhesion and spreading of hamster fibroblasts. Exp Cell Res (1979) 1.35
The structural events associated with the attachment of complement components to cell membranes in reactive lysis. Immunology (1978) 1.32
Lymphocyte activation. IV. The ultrastructural pattern of the response of mouse T and B cells to mitogenic stimulation in vitro. Immunology (1973) 1.29
Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. Eur J Biochem (1974) 1.28
Drug-carrier potential of liposomes in cancer chemotherapy. Lancet (1974) 1.24
Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23
Homing of liposomes to target cells. Biochem Soc Trans (1975) 1.20
Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules. FEBS Lett (1994) 1.19
Nonpilar surface appendages of colony type 1 and colony type 4 gonococci. Infect Immun (1976) 1.18
A new blotting medium for the simple isolation and identification of highly resolved messenger RNA. Nucleic Acids Res (1984) 1.18
Penetration of target areas in the rat by liposome-associated bleomycin, glucose oxidase and insulin. FEBS Lett (1976) 1.15
The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein. Cancer Res (1999) 1.14
Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem Biophys Res Commun (1979) 1.14
The pathology of tumors and other lesions induced in rodents by virus derived from a rat with Moloney leukemia. Cancer Res (1966) 1.13
Ribonucleoprotein of avian infectious bronchitis virus. J Gen Virol (1981) 1.13
Lesions due to complement in lipid membranes. Nature (1971) 1.13
Targeting of drugs: implications in medicine. Lancet (1981) 1.13
Observations on the mechanism of immune hemolysis: importance of immunoglobulin class and source of complement on the extent of damage. J Immunol (1970) 1.12
Liposome-entrapped plasmid DNA: characterisation studies. Biochim Biophys Acta (2000) 1.09
The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett (1980) 1.08
Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br J Exp Pathol (1974) 1.08
Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration). Gastroenterology (1973) 1.08
Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine (2001) 1.07
Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine (1987) 1.06
Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. FEBS Lett (1979) 1.06
Synthesis, characterization and properties of ppp(A2'p)nApCp and related high-specific-activity 32P-labelled derivatives of ppp(A2'p)nA. Eur J Biochem (1981) 1.06
Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization. J Immunol (1989) 1.05
Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues. Life Sci (1977) 1.05
Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response. Immunol Lett (1987) 1.03
Decreased monoamine oxidase activity in liver of iron-deficient rats. Can J Biochem (1969) 1.03
Enzyme entrapment in liposomes. Methods Enzymol (1976) 1.03
Late postoperative results in males treated for testicular torsion during childhood. J Pediatr Surg (1994) 1.03
Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics. Immunology (1987) 1.02
Development of rough endoplasmic reticulum in mouse splenic lymphocytes stimulated by mitogens. Eur J Immunol (1973) 1.02
The preparation and characterization of locust vitellogenin messenger RNA and the synthesis of its complementary DNA. Biochem J (1981) 1.01
Liposomes as vehicles for the local release of drugs. Clin Sci Mol Med (1975) 1.01
Prenatal diagnosis of oculocutaneous albinism by electron microscopy of fetal skin. J Invest Dermatol (1983) 1.00
Attachment of two myxoviruses to ciliated epithelial cells. J Gen Virol (1970) 1.00
Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum. FEBS Lett (1980) 1.00
Is half-life of circulating liposomes determined by changes in their permeability? FEBS Lett (1982) 1.00
Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer. FEBS Lett (1990) 0.99
Interaction of liposomes with blood plasma proteins. Biochem Soc Trans (1976) 0.98
Comparative effect and fate of non-entrapped and liposome-entrapped neuraminidase injected into rats. Biochem J (1974) 0.98
Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue. Eur J Biochem (1994) 0.98
Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2'-5')oligoadenylate synthetase activity. Mol Cell Biol (1983) 0.97
Affinity labelling and characterization of the ppp(A2'p)nA-dependent endoribonuclease from different mammalian sources. Eur J Biochem (1982) 0.96
Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology (1988) 0.96
Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function. Int J Cancer (1997) 0.96
Novel sorbitan monostearate organogels. J Pharm Sci (1999) 0.96
Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase. Lancet (1977) 0.95
Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival. Res Commun Chem Pathol Pharmacol (1975) 0.95
Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta (1985) 0.95
Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept. Ann N Y Acad Sci (1978) 0.94
Mitochondrial ultracondensation, but not swelling, is involved in TNF alpha-induced apoptosis in human T-lymphoblastic leukaemic cells. Leuk Res (1997) 0.94
Electron microscopy of human and mouse myeloma serum IgA. J Mol Biol (1971) 0.94
Electron microscopy of complexes between IgA (MOPC 315) and a bifunctional hapten. J Mol Biol (1971) 0.93
Preparation of liposomes containing factor VIII for oral treatment of haemophilia. J Microencapsul (1989) 0.93
Polysialylated asparaginase: preparation, activity and pharmacokinetics. Biochim Biophys Acta (1997) 0.92
Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies. Biochem Biophys Res Commun (1996) 0.91
Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim Biophys Acta (1996) 0.90
Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers. Biochem J (1981) 0.90
Epithelial patchy necrosis in Crohn's disease. Hum Pathol (1983) 0.89
Tissue and hepatic subcellular distribution of liposomes containing bleomycin after intravenous administration to patients with neoplasms. Clin Sci Mol Med (1976) 0.89
Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target (1994) 0.89
Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. Lancet (1976) 0.89
Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization. Virology (1988) 0.89
The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vitro. Life Sci (1980) 0.88